The tumor immune microenvironment and therapeutic efficacy of trastuzumab deruxtecan in gastric cancer.
Koganemaru S, Koyama S, Suto F, Koga M, Inaki K, Kuwahara Y, Arita T, Hirata T, Goto H, Wada N, Kobayashi M, Shibutani T, Okabayashi T, Nakamaru K, Kawazoe A, Togashi Y, Nishikawa H, Shitara K.
Koganemaru S, et al. Among authors: koyama s.
Cancer Res Commun. 2024 Dec 16. doi: 10.1158/2767-9764.CRC-24-0302. Online ahead of print.
Cancer Res Commun. 2024.
PMID: 39679910
Free article.